drugset / Trial / NCT00171795

Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment

NCT00171795

Phase 3 Completed 67 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to investigate the efficacy and safety of rivastigmine compared with placebo in patients with traumatic brain injury and cognitive impairment.

Timeline

Start
2002-11
Primary completion
2005-05
Completion
2005-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Rivastigmine Small molecule